Navigation Links
HER2 levels may aid in treatment selection for metastatic breast cancer
Date:12/2/2008

PHILADELPHIA Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. In addition, a misclassification of metastatic breast cancer patients by as much as 10 percent prevents some people from receiving optimal therapy.

Lapatinib, an oral chemotherapy agent, inhibits both HER2 and EGRF receptors, leaving unanswered questions about which patients are more likely to benefit. Researchers at the Norris Comprehensive Cancer Center found that HER2 amplification ("HER2-positive"), but not EGRF expression, is correlated with responsiveness to lapatinib. Women with both high and low levels of HER2 amplification respond to lapatinib. However, women with HER2-negative metastatic breast cancers do not respond.

Women with HER2-postitive metastatic breast cancer who receive lapatinib and chemotherapy have shown an improvement of approximately 50 percent in progression-free survival when compared to chemotherapy alone. Unfortunately, high volume laboratories using laboratory technicians instead of pathologists to score gene amplification misclassify approximately 10 percent of HER2 amplified breast cancers as not amplified, preventing these patients from being candidates for lapatinib.

"I would like to see all women with breast cancer tested appropriately, using the best method and certified personnel, to assess the HER2 status of their breast cancer so the appropriate treatment can be selected," said Michael Press, M.D., Ph.D., Norris Comprehensive Cancer Center Harold E. Lee Chair in Cancer Research and lead author of the study.

Currently lapatinib is approved by the FDA for use only in women who have HER2-positive metastatic breast cancer who were previously treated with anthracy
'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. High levels of prenatal smoking exposure affect sleep patterns in preterm neonates
2. FTC Acts to Prevent Tobacco Industry Deception About Tar, Nicotine Levels; Congress Should Give FDA Authority Over Tobacco Products
3. New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
4. Child-Care Relationships Tied to Kids Stress Levels
5. Men who take aspirin have significantly lower PSA levels
6. High-normal phosphate levels linked to early atherosclerosis
7. High Blood Fat Levels Tied to Ischemic Stroke Risk
8. Lipoprotein Levels May Predict Womens Hypertension Risk
9. Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications
10. REVISED AND UPDATED: Firearms Industry Statement on Results of CDC Blood Lead Levels in Hunters Study
11. Firearms Industry Statement on Results of CDC Blood Lead Levels in Hunters Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... 2015 Tunstall Americas announces major investment ... level of service to its Medical Answering Service customers. ... restructuring of resources, Tunstall now provides a seamless transition ... Answering Service to ensure superior patient satisfaction. ... invested over $10 million in expanded facilities and the ...
(Date:5/24/2015)... Orion, Clarkston, Metamora, Michigan (PRWEB) May 24, 2015 ... many patients for concerns about hair loss. Although it ... is clear that there are environmental factors such as ... that can contribute. Since they offer a comprehensive approach ... the peri and post-menopausal woman, they can help patients ...
(Date:5/24/2015)... York, New York (PRWEB) May 24, 2015 ... testosterone treatment lawsuits ( http://www.testosteronelawsuithub.com/ ) has scheduled ... the progress of the multidistrict litigation. According to ... Northern District of Illinois, the Conference will be ... (In re: Testosterone Replacement Therapy Product Liability Litigation ...
(Date:5/24/2015)... May 24, 2015 A report ... that the single best option for avoiding cardiovascular disease ... fitness level was the single most powerful predictor of ... such as diabetes and family history of premature death ... lifelong heart and lung fitness. , The Importance of ...
(Date:5/23/2015)... 23, 2015 On Wednesday, May 20, ... company has been the target of a sophisticated cyberattack,” ... the company’s ongoing Information Technology (IT) security efforts in ... , The most notable attack on health insurers was ... the nation’s second largest health insurer, revealed that they ...
Breaking Medicine News(10 mins):Health News:Tunstall Introduces New Medical Answering Service for the 21st Century Practice 2Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4
... It,s known that people who live or work in rural ... injuries compared to those in more urban environments. But while ... rates, new research suggests that limited access to early, high-quality ... factor. Researchers from St. Michael,s in Toronto looked at ...
... study by doctors at Mount Sinai Hospital in New ... an offshoot of medical tourism, which focuses solely on ... the practice of transplant tourism where patients travel to ... their transplantation. These transplant tourists may be subject ...
... ... ... National Heart Month, and Oldways and the Mediterranean Foods Alliance offer ... the Mediterranean region. Thousands of scientific studies (and the American Heart Association!) declare the Mediterranean ...
... chance of pregnancy by up to 50%, researchers say, , ... to a common chemical that,s used as a flame retardant ... , The chemicals, called PBDEs (polybrominated diphenyl ethers), are found ... carpets, plastics and other common household items and have been ...
... chemo-surgery regimen, researchers say , TUESDAY, Jan. 26 ... promise against locally advanced rectal cancer. , The ... rectal cancer, meaning they have a high likelihood ... receiving standard chemotherapy and optimum surgery. , For ...
... ... Interaction Associates details three essential actions for leaders to move an organization from conflict ... when not handled successfully. To download the white paper, go here: http://bit.ly/8ZcCNt ... Cambridge, ...
Cached Medicine News:Health News:More than 50 percent of injury-related deaths in rural Ontario occur before patients reach hospital 2Health News:More than 50 percent of injury-related deaths in rural Ontario occur before patients reach hospital 3Health News:Transplant tourism poses ethical dilemma for US doctors 2Health News:Transplant tourism poses ethical dilemma for US doctors 3Health News:10 Healthy Med Ways to Show Your Heart Some Love 2Health News:10 Healthy Med Ways to Show Your Heart Some Love 3Health News:Flame-Retardant Chemical Linked to Conception Problems 2Health News:Flame-Retardant Chemical Linked to Conception Problems 3Health News:Intensive Rectal Cancer Treatment Shows Promise 2Health News:From Conflict to Consensus: Interaction Associates Outlines How Leaders Can Achieve Successful Alignment and Implementation 2Health News:From Conflict to Consensus: Interaction Associates Outlines How Leaders Can Achieve Successful Alignment and Implementation 3
(Date:5/22/2015)... 2015 Today, Rhodes Pharmaceuticals L.P. announced that ... indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) ... The announcement comes just one ... U.S. Food and Drug Administration (FDA). ... methylphenidate capsule with an onset of effect of ...
(Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... (Ankle Replacement, Digit Replacement, Elbow Replacement, Hip ... to 2019" report to their offering. ... knee replacement was valued at $4,470.9 million ...
(Date:5/21/2015)... , May 21, 2015  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... quarterly cash dividend for the second quarter 2015 of ... cash dividend of $0.03 per share will be paid ... record as of June 12, 2015.  The ex-dividend date ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2
... AMSTERDAM, December 2 Amsterdam Molecular,Therapeutics ... gene therapy,announced today a number of management changes. Piers ... December 1, 2009. Hans,Preusting, PhD (age 47), Director Process ... and Project Management, also,effective December 1. These changes reflect ...
... BEACH, Calif., Dec. 1 Reproductive Partners Medical Group, ... Program to provide a financial incentive for patients with ... to consider reducing the chance of twins by transferring ... reproductive technology today is reducing the number of multiple ...
Cached Medicine Technology:AMT Announces Management Changes in Light of Refocused Strategy 2AMT Announces Management Changes in Light of Refocused Strategy 3Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: